Stock screenerAll disclosures →
EDGAR →
JAZZ
Conviction 54HealthcareScan · Thu, Sep 24, 2026Hammer
Jazz Pharmaceuticals plc (JAZZ) closed at $236.20 (+0.56%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and above its 200-day moving average. RSI(14) 40, RS Rating 91, -9.7% from its 52-week high, +36.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
JAZZ$236.20+0.56%
ResistanceSupportVol 14Insider sell6
Vol MA14 741.03K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price236.20
Change+0.56%
Gap+0.45%
Rel volume1.30×
Avg volume1.01M
Avg $ vol247.79M
SMA 20243.28
SMA 50248.89
SMA 200209.86
Price vs 50-5.10%
Price vs 200+12.55%
MA stackmixed
50/200 cross—
Supertrenddown · 252.43
RSI (14)40
MACD hist-0.75
MACD cross—
Stoch %K / %D26 / 27
ADX (14)17
+DI / −DI14 / 29
RSI divergence—
MACD divergence—
ATR %2.65%
ADR %2.38%
52w high261.62
52w low127.00
From 52w high-9.72%
Above 52w low+85.98%
New 52w highNo
SqueezeOn · 2d
Bollinger width6.71%
%B0.07
Donchian pos21.68%
Donchian high252.85
Donchian low231.59
AVWAP (52w high)246.37
vs AVWAP high-4.13%
AVWAP (52w low)196.89
vs AVWAP low+19.97%
OBV trendUp
Chaikin MF (20)-0.01
Today vs 20d1.30×
Avg vol (14d)741.03K
Avg vol (20d)1.01M
Avg $ vol (20d)247.79M
Market cap15.33B
RS Rating91 / 99
RS 3m (vs SPY)-0.07%
RS 6m (vs SPY)+8.10%
RS line new highNo
Trend template6/8
Technical rank64.6
1 week-3.13%
1 month-9.23%
3 months+4.42%
6 months+24.92%
1 year+82.53%
YTD+36.41%
P/E-43.05
P/B3.19
P/S3.59
P/FCF11.82
EPS-5.84
Div yield—
ROE-7.42%
ROA-3.21%
Debt/Eq0.91
Current1.78
EV/EBITDA-46.48
Gross margin14.32%
Net margin-8.35%
Rev growth4.88%
EPS growth-163.58%
Price target300.38
Target upside27.17%
Analyst ratingBuy
Institutional109.51%
Ent. value18.06B
Revenue1.21B
Net income192.8M
Gross profit—
Free cash flow1.3B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out62.82M
Employees2.89K
ListedFri, Jun 1, 2007
Free float59.33M
Float %96.4%
Short interest4.62M
Days to cover3.7d
Short volume62.9%
Squeeze score54 / 100
Next earnings—
EPS forecast—
Last EPS vs est$4.89 vs $5.06
Last surprise-3.4% miss
Setup gradeC
Conviction54 / 100
Pattern quality—
Tech rank64.6 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Breaking out nowAug 24 – Aug 252 scans
- Setting upAug 261 scan
Recent news
- Five more years to repay its loans: Jazz Pharmaceuticals (JAZZ) also lowers borrowing margins.Stock Titan · Wed, Sep 23, 2026
- Jazz Pharmaceuticals (JAZZ) Gains Put Its Valuation Story Back In Focussimplywall.st · Wed, Sep 23, 2026
- Jazz Pharmaceuticals plc: Material agreementSEC EDGAR · Wed, Sep 23, 2026
- Jazz Pharmaceuticals stock holds near USD 241.46 as results shape the outlookAD HOC NEWS · Tue, Sep 22, 2026
- Jazz Pharmaceuticals plc (JAZZ) stock price, news, quote and historyYahoo Finance Singapore · Tue, Sep 22, 2026
- Jazz Pharmaceuticals plc (JAZZ) latest stock news and headlines – Yahoo FinanceYahoo Finance Singapore · Tue, Sep 22, 2026
- (JAZZ) Movement as an Input in Quant Signal SetsStock Traders Daily · Tue, Sep 22, 2026
- Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 20% Upside PotentialDirectorsTalk Interviews · Mon, Sep 21, 2026
- Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1BMarketbeat · Sun, Sep 20, 2026
- Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline ExpandsMarketbeat · Sun, Sep 20, 2026
Congress activity
Disclosed STOCK Act trades in JAZZ
No recent disclosed trades by Congress in JAZZ. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in JAZZ · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
COZADD BRUCE C Director · Ordinary Shares · 2026-09-01 | Sell | 6K | $1.5M | 2026-09-01 | 2026-09-02 |
COZADD BRUCE C Director · Ordinary Shares · 2026-08-31 | Tax | 1.21K | $292K | 2026-08-31 | 2026-09-02 |
Cook Jennifer E. Director · Ordinary Shares · 2026-08-31 | Tax | 14 | $3K | 2026-08-31 | 2026-09-02 |
Cook Jennifer E. Director · Ordinary Shares · 2026-08-31 | Tax | 1.69K | $408K | 2026-08-31 | 2026-09-02 |
ENRIGHT PATRICK G Director · Ordinary Shares · 2026-08-31 | Tax | 14 | $3K | 2026-08-31 | 2026-09-02 |
ENRIGHT PATRICK G Director · Ordinary Shares · 2026-08-31 | Tax | 1.69K | $408K | 2026-08-31 | 2026-09-02 |
Hamill Laura Director · Ordinary Shares · 2026-08-31 | Tax | 14 | $3K | 2026-08-31 | 2026-09-02 |
Hamill Laura Director · Ordinary Shares · 2026-08-31 | Tax | 1.69K | $408K | 2026-08-31 | 2026-09-02 |
Henderson Mary Elizabeth SVP, Technical Operations · Ordinary Shares · 2026-08-31 | Tax | 2.08K | $501K | 2026-08-31 | 2026-09-02 |
Henderson Mary Elizabeth SVP, Technical Operations · Ordinary Shares · 2026-08-31 | Tax | 16 | $4K | 2026-08-31 | 2026-09-02 |
SEC filings
EDGAR filings in JAZZ · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.